NEWS & EVENTS

PR Newswire: GrayMatters Health Continues to Broaden Patient Access of Prism for PTSD™ Across the US

PR Newswire: GMH Expands Veteran and Civilian Access to FDA-Cleared Prism for PTSD™ Treatment

PR Newswire: Edison Gold Award for Prism for PTSD

APA 2024: Meet us at Booth #1628, Javits Convention Center, NYC

Fast Company: How this company is putting a lid on PTSD​

PR Newswire: GrayMatters Health Named to Fast Company's list of World's Most Innovative Companies (MIC) of 2024

Psychiatric Times: Study Highlights Efficacy of Prism for PTSD in Alleviating Chronic PTSD Symptoms

nocamels: Brain Activity Monitor Proves Efficacy in PTSD Therapy, Study Finds

PR Newswire: GrayMatters Health Announces Pioneering Study Highlighting Safety and Efficacy of Self-Neuromodulation for PTSD

PR Newswire: GrayMatters Launches New FDA-Cleared Self-Neuromodulation PTSD Therapy in the United States

Globes: Israeli startup GrayMatters treats PTSD with avatars

MM+M: ‘What we do matters’: Israeli mental health startup finds mission especially vital

HIT Consultant: The Future of Biomarker-Based Therapy for Mental Disorder Care by Oded Kraft, Co-Founder & CEO of GrayMatters Health

Medical Device News Magazine: GrayMatters Health Expands US Executive Team, Including Appointment of Dr Aron Tendler as Chief Medical Office

PR Newswire: GrayMatters Health Expands US Executive Team

PR Newswire: GrayMatters Health Wins 2023 Prix Galien USA Best Startup Award

PR Newswire: GrayMatters Health Appoints Kirk Thelander as Chief Commercial Officer

ISRAEL21c: Neurofeedback device helps PTSD sufferers regain control over emotions

Medgadget: Digital Self-Neuromodulation Therapy for PTSD: Interview with Oded Kraft, CEO of GrayMatters Health

The Healthcare Technology Report: Retrain The Brain: GrayMatters Health Carves Out New PTSD Treatment Option

FIERCE Biotech: Neuromodulation device for PTSD treatment from GrayMatters snags FDA nod

PR Newswire: U.S. FDA Grants GrayMatters Health 510(k) Clearance to Market Prism for PTSD

PR Newswire: GrayMatters Health Receives Investment from European Innovation Council (EIC) Fund

GrayMatters Health Chosen as a Falling Walls Venture 2022 Winner

GrayMatters Health Awarded €2.5M in Funding from European Innovation Council

PR Newswire: GrayMatters Health Closes $10M Round A Funding and Partnership in Japan

PR Newswire: McLean Hospital and GrayMatters Health Awarded BIRD Foundation Grant to Develop Digital Therapy for Major Depression Disorder with Anhedonia Symptoms

PR Newswire: GrayMatters Health Wins Awards for its Innovative Technology for the Treatment of Mental Disorders

Beyond the Pill: a startup reimagines mental health